Avanish Vellanki - Net Worth and Insider Trading
Avanish Vellanki Net Worth
The estimated net worth of Avanish Vellanki is at least $3 Million dollars as of 2024-11-13. Avanish Vellanki is the Chairman and CEO, 10% Owner of Rain Oncology Inc and owns about 2,471,627 shares of Rain Oncology Inc (RAIN) stock worth over $3 Million. Details can be seen in Avanish Vellanki's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Avanish Vellanki has not made any transactions after 2022-06-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Avanish Vellanki
Avanish Vellanki Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Avanish Vellanki owns 1 companies in total, including Rain Oncology Inc (RAIN) .
Click here to see the complete history of Avanish Vellanki’s form 4 insider trades.
Insider Ownership Summary of Avanish Vellanki
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RAIN | Rain Oncology Inc | 2022-06-01 | director & President and CEO |
Avanish Vellanki Latest Holdings Summary
Avanish Vellanki currently owns a total of 1 stock. Avanish Vellanki owns 2,471,627 shares of Rain Oncology Inc (RAIN) as of June 1, 2022, with a value of $3 Million.
Latest Holdings of Avanish Vellanki
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RAIN | Rain Oncology Inc | 2022-06-01 | 2,471,627 | 1.21 | 2,990,669 |
Holding Weightings of Avanish Vellanki
Avanish Vellanki Form 4 Trading Tracker
According to the SEC Form 4 filings, Avanish Vellanki has made a total of 1 transactions in Rain Oncology Inc (RAIN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Rain Oncology Inc is the acquisition of 25,000 shares on June 1, 2022, which cost Avanish Vellanki around $57,250.
Insider Trading History of Avanish Vellanki
- 1
Avanish Vellanki Trading Performance
GuruFocus tracks the stock performance after each of Avanish Vellanki's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Avanish Vellanki is 94.67%. GuruFocus also compares Avanish Vellanki's trading performance to market benchmark return within the same time period. The performance of stocks bought by Avanish Vellanki within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Avanish Vellanki's insider trading performs compared to the benchmark.
Performance of Avanish Vellanki
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 120.49 | | | | | |
| Relative Return to S&P 500(%) | 127.22 | | | | | |
Avanish Vellanki Ownership Network
Ownership Network List of Avanish Vellanki
Ownership Network Relation of Avanish Vellanki
Avanish Vellanki Owned Company Details
What does Rain Oncology Inc do?
Who are the key executives at Rain Oncology Inc?
Avanish Vellanki is the director & President and CEO of Rain Oncology Inc. Other key executives at Rain Oncology Inc include 10 percent owner Kevin C Tang , Principal Fin. & Acc. Officer Josephine Bruce , and 10 percent owner Tang Capital Partners Lp .
Rain Oncology Inc (RAIN) Insider Trades Summary
Over the past 18 months, Avanish Vellanki made no insider transaction in Rain Oncology Inc (RAIN). Other recent insider transactions involving Rain Oncology Inc (RAIN) include a net purchase of 1,198,445 shares made by Kevin C Tang , and a net sale of 995,000 shares made by Boxer Capital, Llc .
In summary, during the past 3 months, insiders sold 0 shares of Rain Oncology Inc (RAIN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,168,973 shares of Rain Oncology Inc (RAIN) were sold and 1,372,418 shares were bought by its insiders, resulting in a net purchase of 203,445 shares.
Rain Oncology Inc (RAIN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rain Oncology Inc Insider Transactions
Avanish Vellanki Mailing Address
Above is the net worth, insider trading, and ownership report for Avanish Vellanki. You might contact Avanish Vellanki via mailing address: 8000 Jarvis Avenue, Suite 204, Newark Ca 94560.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
